Catalyst Biosciences, Inc.

CBIO

CBIO
Catalyst Biosciences, Inc. Stock Quote
$5.37 -$0.03 -0.6%
Price as of August 6, 2020, 4:30 p.m. EDT View Interactive CBIO Charts

A biopharmaceutical company engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of multiple diseases and disorders of the central nervous system.

Interactive Chart


News & Analysis: Catalyst Biosciences, Inc.

All









Last Week's Biggest Stock Laggards

The market roared ahead last week, but some stocks and sectors weren't able to keep up with the rest of the market.